Decrease in Temperature as a Pagtonomic Sign by Scorpion Sting

August 13, 2019 updated by: Josue Saul Almaraz Lira, Mexican Red Cross

Decrease in Temperature by Scorpion Sting: a Pagtonomic Sign

The scorpion sting is a medical disease, for the signs and symptoms presented; Sometimes patients do not know the animal that causes these symptoms; the bibliography marks the decrease in temperature as a sign to be presented.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The scorpion sting is a medical emergency where 184 patients from the state of Guanajuato were divided into 2 groups according to the type of antivenom administered, the dose of antivenom were at the discretion of the attending physician, Birmex (n = 117) and Alacramyn (n = 67) for the temperature record of the site of sting and other vital signs, this to compare it with the bibliography as a pathognomonic sign.

Study Type

Observational

Enrollment (Actual)

184

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Mexico
    • Guanajuato
      • León, Guanajuato, Mexico, 37179
        • Cruz Roja Mexicana, Delegación León

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 90 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Person who has been scorpion sting and present signs and symptoms of poisoning to will applied a treatment in the city of León, Guanajuato

Description

Inclusion Criteria:

  • Scorpion sting
  • All sex
  • 3 - 90 ages

Exclusion Criteria:

  • Application of ice at the sting site

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Patients who apply anti-scorpion venom serum Birmex at the discretion of the attending physician were given vital signs.
Diagnostic test: Vital signs
Axillary temperature sampling, at the site of the scorpion sting and the contralateral site with infrared thermometer, and heart rate, respiratory rate and blood pressure on admission, 30 minutes after applying the vial and the medical discharge
2
Patients who apply anti-scorpion venom serum Alacramyn at the discretion of the attending physician were given vital signs.
Diagnostic test: Vital signs
Axillary temperature sampling, at the site of the scorpion sting and the contralateral site with infrared thermometer, and heart rate, respiratory rate and blood pressure on admission, 30 minutes after applying the vial and the medical discharge

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Temperature change
Time Frame: 0, 30 and 120 minutes
Temperature at the sting site, contralateral site and axillary in degrees celcius
0, 30 and 120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood preasure
Time Frame: 0, 30 and 120 minutes
Systolic and diastolic in mmHg
0, 30 and 120 minutes
Heart rate
Time Frame: 0, 30 and 120 minutes
Beats per minute
0, 30 and 120 minutes
Respiratory rate
Time Frame: 0, 30 and 120 minutes
Breaths per minute
0, 30 and 120 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Mexican Red Cross

Collaborators

Instituto Bioclon S.A. de C.V.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2017

Primary Completion (Actual)

June 15, 2017

Study Completion (Actual)

July 30, 2017

Study Registration Dates

First Submitted

July 24, 2018

First Submitted That Met QC Criteria

August 4, 2018

First Posted (Actual)

August 9, 2018

Study Record Updates

Last Update Posted (Actual)

August 15, 2019

Last Update Submitted That Met QC Criteria

August 13, 2019

Last Verified

August 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CRM-Alacranes-2017

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scorpion Stings

Clinical Trials on Vital signs

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe